Chinese Market for Medical Imaging Equipment to Exceed $2.5 billion by 2016
FARMINGTON, Conn., Aug. 8, 2012 /PRNewswire-iReach/ -- Medical imaging is a highly advanced technology segment in the already-advanced medical diagnostics market, encompassing everything from MRI to CT, from X-Ray to Ultrasound equipment. As the BRIC nations (Brazil, Russia, India, and China) continue their march toward modernization, the market for such advanced equipment will continue to grow. As these economies – and the rest of the world – emerge from recession into a new period of growth, knowing which technologies will hit their stride – and which ones will stumble – will be essential to businesses, investors, governments, and watch-dogs looking to capitalize on the shifting market.
Chinese Markets for Diagnostic Imaging Systems 2012
The Chinese market for diagnostic imaging equipment will grow over the next five years to over $2.5 billion, including MRI, CT, x-ray, ultrasound, and nuclear medicine systems. This rise comes due to an increase in government funding for health care in China. The Chinese government is looking to minimize the large gap in health care quality between rural and urban hospitals, so more funding will be supplied to rural hospitals to adopt diagnostic imaging systems, which will contribute heavily to the lower-end diagnostic imaging system segments.
Meanwhile, more affluent hospitals will replace their outdated systems with higher-end or premium systems. Despite these purchases, price erosion will occur due to heavy competition among domestic competitors, especially within low-end systems. The majority of the market will be dominated by multinational companies because of physician preference for high brand awareness in affluent hospitals in order to attract wealthy patients.
An executive summary and free sample pages from the full study are available at http://www.giiresearch.com/report/mrg80764-cn-diagno-imagi.html
Medical Imaging Markets: Contrast Agents
Today's capabilities in clinical diagnostic radiology have been made possible by advances not only in diagnostic systems, but also by the contrast media and radiopharmaceuticals that make it possible to see, in great detail, the body's internal structures, organs and tissue that would not otherwise be clearly seen. Although bones are readily apparent on radiographic images, other organs and tissues are not. These imaging agents may be used during a medical imaging procedure to highlight specific parts of the body and make them easier to visualize. The application and versatility of medical imaging modalities are continuing to grow in significance as the population ages and healthcare costs rise. Examinations that can facilitate earlier disease diagnosis and the most appropriate treatment are in order. This bodes well for contrast media markets.
Generally, the market for contrast agents and radiopharmaceuticals is expected to sustain decent growth in the next few years, with much of that growth coming from the MRI, ultrasound and nuclear medicine modalities. While equipment manufacturers may have experienced a slump in sales due to the recent recession, there is still a need for these agents, as well as for radiopharmaceuticals, to help image, track and diagnose disease, especially in the elderly. Even though hospitals and clinics may have slowed their equipment purchases because of the need to contain costs, procedures run on installed systems still require the use of contrast agents and radiopharmaceuticals.
An Executive Summary of this analysis and a free sample of the full report are available at http://www.giiresearch.com/report/kl102354-med-image-contr.html
China Computed Radiography (CR) Market Assessment and Outlook 2012-2015
China's recent economic growth and increasing attention on healthcare for its large, older population has created various new opportunities in medical devices markets. In recent years, Chinese hospitals have focused on investing in new, advanced medical imaging equipment. This report examines patterns in the Computed Radiology (CR) equipment market and provides an in-depth analysis of the CR market in China. The report outlines China's CR market, including user survey results and analysis, market size and segmentation, market shares, a market forecast, and brief supplier profiles. The report also examines hospital purchasing plans and procedures, total sales of CRs, and CR market shares. This study draws from first-hand interviews and also includes a survey of Chinese hospitals containing more than 100 beds. For this study, a total of 329 in-depth interviews with different market participants (hospitals and suppliers) were conducted.
An Executive Summary and a free sample of the full report are available at http://www.giiresearch.com/report/mcr246351-china-computed-radiography-cr-market-assessment.html
Medical Imaging Markets
The purpose of this new market research report is to describe the specific market segment of the diagnostics market sector called medical imaging. Medical imaging can be categorized into nine main modalities: X-ray, ultrasound, computed tomography (CT), positron emission tomography (PET), single photon emission tomography (SPECT), magnetic resonance imaging (MRI), nuclear medicine (NM), mammography and fluoroscopy. Globally, X-ray is the most frequently used imaging procedure with about 108 million X-ray exams per year. MRI is second with 26 million examinations per year. PET, SPECT, CT and nuclear medicine rank third with 30 million examinations per year
This report surveys almost all of the companies known to be marketing, manufacturing or developing medical imaging equipment and supplies in the world. Each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company's market position. Detailed tables and charts with sales forecasts and market share data are also included.
An Executive Summary and a free sample of the full report are available at http://www.giiresearch.com/report/tk189538-medical-imaging.html
About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.
Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Global Information, Inc.
More by this Source
Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts
May 22, 2013, 16:28 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.